Journal
FRONTIERS IN CELLULAR NEUROSCIENCE
Volume 14, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2020.575082
Keywords
hippocampus; myelin; OPC; oligodendrocyte progenitor cell; Alzheimer’ s disease
Categories
Funding
- Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M029379/1]
- Medical Research Council (MRC) [MR/P025811/1]
- Alzheimer's Research UK [ARUK-PPG2014B-2]
- University of Portsmouth
- Programme Avenir Lyon Saint-Etienne
- BBSRC [BB/M029379/1] Funding Source: UKRI
- MRC [MR/P025811/1] Funding Source: UKRI
Ask authors/readers for more resources
Myelin disruption is a feature of natural aging and Alzheimer's disease (AD). In the CNS, myelin is produced by oligodendrocytes, which are generated throughout life by oligodendrocyte progenitor cells (OPCs). Here, we examined age-related changes in OPCs in APP/PS1 mice, a model for AD-like pathology, compared with non-transgenic (Tg) age-matched controls. The analysis was performed in the CA1 area of the hippocampus following immunolabeling for NG2 with the nuclear dye Hoescht, to identify OPC and OPC sister cells, a measure of OPC replication. The results indicate a significant decrease in the number of OPCs at 9 months in APP/PS1 mice, compared to age-matched controls, without further decline at 14 months. Also, the number of OPC sister cells declined significantly at 14 months in APP/PS1 mice, which was not observed in age-matched controls. Notably, OPCs also displayed marked morphological changes at 14 months in APP/PS1 mice, characterized by an overall shrinkage of OPC process domains and increased process branching. The results indicate that OPC disruption is a pathological sign in the APP/PS1 mouse model of AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available